BGI Group

Home
China
Shenzhen
BGI Group

Website Contact the museum

BGI was founded privately in 1999 to participate in the renowned Human Genome Project.

BGI Group, a pioneer in life sciences, is one of the world’s leading biotechnology organizations with operations covering research, production, and applications in more than 100 countries and regions. It expanded scope through news business since 2007 and now it supports the genomics-related project with customers across the world.

06/10/2026

BGI-Research, Yazhouwan National Laboratory, and collaborating institutions have reported in Cell a spatiotemporal lifecycle atlas of rice.

By combining single-nucleus RNA sequencing with BGI’s Stereo-seq spatial transcriptomics, the study maps gene activity across rice cells, tissues, and developmental stages, from germinating seed to maturing grain. The atlas provides a detailed resource for understanding how rice plants grow, how grain develops, and how different molecular programs shape the endosperm, the part of the grain that makes up most of the rice we eat.

The study offers a foundation for future work in plant development, grain filling, and crop improvement.

Read the study: https://en.genomics.cn/en-scientificdiscoverie-7655.html

05/10/2026

There are more than 3,000 types of skin diseases, and many are highly prone to recurrence.

At ICG-21, Dr. Guanxiong Zhang spoke about the real burden of skin diseases and the need to better understand healthy skin first. His work on a healthy skin atlas aims to reveal the molecular characteristics of skin across different body sites.

With omics technologies and AI, researchers can integrate data from molecules, clinical images, and medical records. This could help improve precision diagnosis and treatment, and bring higher-quality dermatological care to more hospitals.

05/10/2026

On October 4, BGI Group’s Humanitarian Response Task Force arrived in Nepal to support the China–Nepal emergency cross-border scientific expedition following the August 26 extreme geological disaster in the central Himalayas.

The disaster, triggered by a high-altitude ice-rock collapse on the northern slope of Langtang Lirung, evolved into a destructive debris-flow chain, causing casualties and property losses in both China and Nepal.

As part of the joint expedition, BGI will provide professional support for human remains identification through forensic DNA analysis, working in coordination with the China–Nepal scientific team and relevant Nepali authorities. Each confirmed identity matters deeply to the families awaiting answers.

BGI brings long-standing expertise in genomics and forensic DNA identification, with previous humanitarian missions including the 2004 Indian Ocean tsunami response in Thailand and the 2018 Laos dam-collapse disaster.

Guided by scientific rigor, humanitarian principles, and respect for local laws and procedures, BGI is committed to helping bring dignity to the deceased and comfort to their loved ones.

Photo: Group Photo of Participants of the Joint Scientific Expedition on Transboundary Central Himalayan Cascading Hazards 2026

02/10/2026

Rare diseases are not as rare as many people think.

At ICG-21, Prof. Ya Zhang shared that rare diseases affect around 300 million people worldwide. Yet diagnosis remains extremely difficult because there are more than 7,000 rare diseases, many with overlapping symptoms and limited data.

Prof. Zhang highlighted how AI can help. By using symptoms to identify possible diseases and combining this with genetic sequencing to confirm pathogenic variants, AI may support a more systematic approach to rare disease diagnosis.
The future of rare disease breakthroughs may lie in the integration of AI, genomics, and platform-based medical innovation.

30/09/2026

BGI Group and Indonesian partners came together at the Indonesia Omics Innovation and Application Forum 2026 in Jakarta to advance collaboration in genomics and precision health.

During the forum, BGI Group and Indonesia’s Center for Biomedical and Health Genomics, under the Ministry of Health, signed agreements to strengthen collaboration in support of the country’s Biomedical and Genome Science Initiative (BGSi).

The event featured discussions with health officials, clinicians, researchers and industry partners on the role of genomics, multi-omics and AI in areas including reproductive health, rare diseases, cancer, infectious diseases, aging and preventive health.

BGI looks forward to continuing collaboration with Indonesian partners to support local research capacity, clinical applications, talent development and sustainable omics services.

Read: https://en.genomics.cn/en-news-7654.html

24/09/2026

BGI Group’s strategic partner in Mexico, Géntodos Genómica Para Todos, has officially opened the Géntodos Multi-omics Center in Mexico City.

This opening marks an important milestone in the collaboration between Géntodos and BGI Group, advancing efforts to strengthen genomic testing capabilities and support the development of precision medicine in Mexico. The center brings together sample processing, genomic sequencing, result interpretation, and clinical decision support within an integrated laboratory workflow, helping expand local access to advanced genomic technologies.

Together, Géntodos and BGI Group aim to enhance genomic testing capacity, broaden access to multi-omics solutions, and support the continued growth of precision medicine in Mexico and across Latin America.

Read more: https://en.genomics.cn/en-news-7653.html

(Photo: On September 23, BGI Group’s strategic partner in Mexico, Géntodos Genómica Para Todos (Géntodos), officially opened its Multi-omics Center in Mexico City. A group photo of the executives attending the opening ceremony.)

18/09/2026

What changes in the body when exercise becomes a regular habit?

A new study from BGI-Research, Shanxi Medical University and partners, published in Science Advances, used data from the Chinese Immune Multi-Omics Atlas (CIMA) to examine blood samples from regular exercisers and sedentary controls.

By combining plasma metabolomics, lipidomics, single-cell transcriptomics and chromatin accessibility analysis, the team found exercise-associated signatures in metabolism and immune cells, including pathways related to antigen presentation, antioxidant defense and cytotoxic immune-cell function.

The findings add to our understanding of how regular physical activity may support health at the molecular and cellular level, and demonstrate the value of BGI’s multi-omics research platforms in population health studies.

Read more: https://en.genomics.cn/en-scientificdiscoverie-7638.html

17/09/2026

BGI Group was pleased to contribute to STOC Plant 2026 in Perth, Australia, where more than 200 participants from 10 countries gathered to discuss the future of crop spatiotemporal multi-omics.

The conference focused on moving from atlas construction to trait discovery, predictive modeling, and practical breeding applications. BGI Group contributed to discussions on multi-omics data integration, AI-enabled models, and collaborative platforms for crop research.

During the event, BGI Group and Murdoch University signed a memorandum of understanding to strengthen cooperation in research, researcher exchanges, and platform development. The conference also saw the launch of the Barley Spatial Omics Consortium and continued collaboration within the Wheat Spatial Omics Consortium.

BGI Group will continue working with international partners to support open data resources, advanced omics technologies, and research platforms that contribute to crop improvement, food security, and sustainable agriculture.

Read more: https://en.genomics.cn/en-news-7636.html

09/09/2026

BGI Group celebrated its 27th anniversary with the 2026 Global New Product Launch Event in Shenzhen.

Guided by the theme “Intelligent Life · Infinite Health,” BGI introduced new technologies spanning brain science, multi-omics research computing, active health management, personalized nutrition, skincare, pet health, and soil ecology.

These innovations reflect BGI’s ongoing commitment to making life science more intelligent, accessible, and impactful. From understanding brain organoids and biological age to supporting precision nutrition, pet health, and soil ecology, BGI is proud to help expand what is possible in health and life science.

As we enter our 28th year, BGI will continue advancing genomic technologies and intelligent life science tools to support healthier lives, stronger research, and a more sustainable future.

Learn more: https://en.genomics.cn/en-news-7633.html

08/09/2026

ICG-21 was held in Shenzhen from September 7 to 8 under the theme “Bio-Generative Intelligence for Health.”

Over two days, the conference brought together global experts in genomics, AI, multi-omics, medicine, brain technology, regenerative innovation, public health, education, and well-being.

From keynote sessions to five parallel academic tracks on Beauty, Health, Longevity, Wisdom, and Well-being, ICG-21 continued to support open scientific exchange and collaboration across life sciences.

We sincerely thank all speakers, participants, partners, and organizing colleagues who joined us in Shenzhen and contributed to the success of ICG-21.

ICG will continue to uphold the spirit of “Owned by All, Done by All, and Shared by All,” and work with the global life science community to advance health and well-being for all.

Read: https://en.genomics.cn/en-news-7632.html

Address

Building 11, Beishan Industrial Zone, Yantian District
Shenzhen
518083

Website

http://en.genomics.cn/

Alerts

Be the first to know and let us send you an email when BGI Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Museum

Send a message to BGI Group:

Want your museum to be the top-listed museum in Shenzhen?